LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.925
AS - Asia 1.751
EU - Europa 1.511
SA - Sud America 234
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.453
Nazione #
US - Stati Uniti d'America 3.838
SG - Singapore 731
CN - Cina 505
IT - Italia 327
DE - Germania 288
PL - Polonia 270
BR - Brasile 201
FI - Finlandia 151
HK - Hong Kong 148
GB - Regno Unito 126
TR - Turchia 125
VN - Vietnam 100
UA - Ucraina 97
SE - Svezia 63
CA - Canada 41
ID - Indonesia 40
RU - Federazione Russa 40
MX - Messico 37
BE - Belgio 30
IN - India 23
NL - Olanda 20
RO - Romania 17
AT - Austria 16
CZ - Repubblica Ceca 16
FR - Francia 16
ZA - Sudafrica 16
BD - Bangladesh 15
AR - Argentina 13
JP - Giappone 11
ES - Italia 9
IQ - Iraq 9
LT - Lituania 9
IR - Iran 7
EC - Ecuador 6
IE - Irlanda 6
KZ - Kazakistan 5
CL - Cile 4
PE - Perù 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
NP - Nepal 3
PK - Pakistan 3
SA - Arabia Saudita 3
TW - Taiwan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MQ - Martinica 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.453
Città #
Ashburn 454
Fairfield 430
Singapore 392
Woodbridge 349
Warsaw 268
Houston 227
Ann Arbor 222
Chandler 203
Beijing 201
Seattle 177
Munich 171
Santa Clara 170
Hong Kong 148
Cambridge 135
Wilmington 128
Jacksonville 125
Ferrara 113
Dallas 103
New York 99
Helsinki 75
Izmir 66
Los Angeles 65
Milan 47
Turku 47
Nanjing 45
Shanghai 42
Princeton 37
Jakarta 36
Ho Chi Minh City 33
Brussels 30
San Diego 27
Mexico City 26
London 24
Boardman 23
Nanchang 21
Chicago 20
Bremen 19
Buffalo 19
São Paulo 19
Tianjin 19
Addison 17
Phoenix 17
Timisoara 17
Denver 16
Falls Church 16
Hanoi 16
Rome 15
Brooklyn 14
Johannesburg 14
Orem 14
Brno 13
Dong Ket 13
Shenyang 13
Toronto 13
Atlanta 12
Changsha 12
Montreal 12
The Dalles 12
Council Bluffs 11
Nuremberg 11
Stockholm 11
Tokyo 11
Bologna 10
Boston 10
Poplar 10
Redwood City 10
Dearborn 9
Hebei 9
San Jose 9
Amsterdam 8
Chennai 8
Columbus 8
Kunming 8
Manchester 8
Moscow 8
Rio de Janeiro 8
San Francisco 8
Frankfurt am Main 7
Washington 7
Auburn Hills 6
Dublin 6
Falkenstein 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Vienna 6
Ankara 5
Brasília 5
Ferrara di Monte Baldo 5
Guarulhos 5
Haiphong 5
Naples 5
Ningbo 5
Philadelphia 5
Tampa 5
Belo Horizonte 4
Cagliari 4
Da Nang 4
Des Moines 4
Totale 5.409
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 280
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 268
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 261
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 254
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 250
Ruolo del miR-221 nella tumorigenesi epatica 245
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 236
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 227
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 224
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 221
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 214
Circulating non-coding RNA as biomarkers in colorectal cancer 209
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 208
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 206
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 205
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 203
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 188
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 188
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 184
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 183
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 182
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 181
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 173
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 169
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 164
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 161
Oncogenic role of miR-483-3p at the IGF2/483 locus 149
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 147
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 142
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 139
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 138
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 136
Mutated beta-catenin evades a microRNA-dependent regulatory loop 134
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 132
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 131
The importance of microRNAs in RAS oncogenic activation in human cancer 126
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 119
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 94
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 91
null 89
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 84
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 81
null 77
null 63
Totale 7.556
Categoria #
all - tutte 34.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.513
Totale 36.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 0 0 0 80 33 66 24 147 87 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20261.871 389 135 267 394 502 184 0 0 0 0 0 0
Totale 7.556